Immunologic and Hemodynamic Effects of “Low-Dose” Hydrocortisone in Septic Shock: A Double-Blind, Randomized, Placebo-controlled, Crossover Study
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Within the last few years, increasing evidence of relative adrenal insufficiency in septic shock evoked a reassessment of hydrocortisone therapy. To evaluate the effects of hydrocortisone on the balance between proinflammatory and antiinflammation, 40 patients with septic shock were randomized in a double-blind crossover study to receive either the first 100 mg of hydrocortisone as a loading dose and 10 mg per hour until Day 3 (n = 20) or placebo (n = 20), followed by the opposite medication until Day 6. Hydrocortisone infusion induced an increase of mean arterial pressure, systemic vascular resistance, and a decline of heart rate, cardiac index, and norepinephrine requirement. A reduction of plasma nitrite/nitrate indicated inhibition of nitric oxide formation and correlated with a reduction of vasopressor support. The inflammatory response (interleukin-6 and interleukin-8), endothelial (soluble E-selectin) and neutrophil activation (expression of CD11b, CD64), and antiinflammatory response (soluble tumor necrosis factor receptors I and II and interleukin-10) were attenuated. In peripheral blood monocytes, human leukocyte antigen-DR expression was only slightly depressed, whereas in vitro phagocytosis and the monocyte-activating cytokine interleukin-12 increased. Hydrocortisone withdrawal induced hemodynamic and immunologic rebound effects. In conclusion, hydrocortisone therapy restored hemodynamic stability and differentially modulated the immunologic response to stress in a way of antiinflammation rather than immunosuppression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study found that hydrocortisone treatment reduced the levels of anti-inflammatory cytokines such as soluble TNF receptors I and II and IL-10, and has only limited effects on HLA-DR expression by circulating monocytes [29].”
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Radomski, M. W., Palmer, R. M., & Moncada, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.10043 · Cited by 1,096
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000
Sir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989
Briegel, J., Forst, H., Haller, M., Schelling, G., Kilger, E., Kuprat, G., Hemmer, B., Hummel, T., Lenhart, A., Heyduck, M., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199904000-00025 · Cited by 889
Reversal of late septic shock with supraphysiologic doses of hydrocortisone
Bollaert, P.-E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., & Larcan, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00010 · Cited by 872
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Sprung, C. L., Caralis, P. V., Marcial, E. H., Pierce, M., Gelbard, M. A., Long, W. M., Duncan, R. C., Tendler, M. D., & Karpf, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111801 · Cited by 765
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Leucocyte-endothelial interactions and regulation of leucocyte migration
Adams, D. H., & Shaw, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92029-x · Cited by 575
Elenkov, I. J., Papanicolaou, D. A., Wilder, R. L., & Chrousos, G. P. (1996) · PubMed · Cited by 495
Steroid controversy in sepsis and septic shock: A meta-analysis
Lefering, R., & Neugebauer, E. A. M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199507000-00021 · Cited by 485
Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro
Ramírez, F., Fowell, D. J., Puklavec, M., Simmonds, S., & Mason, D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2406 · Cited by 483
Calandra, T., Gerain, J., Heumann, D., Baumgartner, J.-D., & Glauser, M. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90069-a · Cited by 442
Cortisol response to corticotropin and survival in septic shock
ROTHWELL, P. (1991) · The Lancet · doi:10.1016/0140-6736(91)91641-7 · Cited by 412
Monocyte deactivation-rationale for a new therapeutic strategy in sepsis
Volk, H. D., Reinke, P., Krausch, D., Zuckermann, H., Asadullah, K., Müller, J. M., Döcke, W. D., & Kox, W. J. (1996) · Intensive Care Medicine · doi:10.1007/bf01743727 · Cited by 361
Self-citationEffects of Nitric Oxide in Septic Shock
VINCENT, J.-L., ZHANG, H., SZABO, C., & PREISER, J.-C. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9812004 · Cited by 351
Glucocorticoids and immune function: unknown dimensions and new frontiers
Wilckens, T., & De Rijk, R. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01111-0 · Cited by 351
Annane, Bellissant, Sebille, Lesieur, Mathieu, Raphael, & Gajdos (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00833.x · Cited by 291
Soni, A., Pepper, G. M., Wyrwinski, P. M., Ramirez, N. E., Simon, R., Pina, T., Gruenspan, H., & Vaca, C. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80373-8 · Cited by 277
The role of nitric oxide in sepsis – an overview
Kirkebøen, K. A., & Strand, Ø. A. (1999) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.1999.430307.x · Cited by 277
Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y.-J., Aringer, M., Frucht, D. M., Chrousos, G. P., & O’Shea, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1768 · Cited by 260
The role of corticosteroids in the regulation of vascular tone
Ullian, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00230-2 · Cited by 260
Sepsis and serum cytokine concentrations
Damas, P., Canivet, J.-L., De Groote, D., Vrindts, Y., Albert, A., Franchimont, P., & Lamy, M. (1997) · Critical Care Medicine · doi:10.1097/00003246-199703000-00006 · Cited by 252
SIBBALD, W. J., SHORT, A., COHEN, M. P., & WILSON, R. F. (1977) · Annals of Surgery · doi:10.1097/00000658-197707000-00005 · Cited by 249
MARTY, C., MISSET, B., TAMION, F., FITTING, C., CARLET, J., & CAVAILLON, J.-M. (1994) · Critical Care Medicine · doi:10.1097/00003246-199404000-00025 · Cited by 212
Leukocyte activation in sepsis; correlations with disease state and mortality
Muller Kobold, A. C., Tulleken, J. E., Zijlstra, J. G., Sluiter, W., Hermans, J., Kallenberg, C. G. M., & Cohen Tervaert, J. W. (2000) · Intensive Care Medicine · doi:10.1007/s001340051277 · Cited by 203
Simmons, W. W., Ungureanu-Longrois, D., Smith, G. K., Smith, T. W., & Kelly, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23928 · Cited by 186
Tschaikowsky, K., Hedwig-Geissing, M., Schiele, A., Bremer, F., Schywalsky, M., & Schüttler, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00010 · Cited by 182
COWLEY, H. C., HENEY, D., GEARING, A. J. H., HEMINGWAY, I., & WEBSTER, N. R. (1994) · Critical Care Medicine · doi:10.1097/00003246-199404000-00022 · Cited by 178
T-cell reactivity and its predictive role in immunosuppression after burns
Zedler, S., Bone, R. C., Baue, A. E., von Donnersmarck, G. H., & Faist, E. (1999) · Critical Care Medicine · doi:10.1097/00003246-199901000-00028 · Cited by 163
Kox, W. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440250031004 · Cited by 160
A comparison of the adrenocortical response during septic shock and after complete recovery
Briegel, J., Schelling, G., Haller, M., Mraz, W., Forst, H., & Peter, K. (1996) · Intensive Care Medicine · doi:10.1007/bf02044113 · Cited by 158
Glucocorticoid Receptor Regulates Expression of L-Selectin and CD11/CD18 on Human Neutrophils
Filep, J. G., Delalandre, A., Payette, Y., & Földes-Filep, E. (1997) · Circulation · doi:10.1161/01.cir.96.1.295 · Cited by 153
Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome
Briegel, J., Kellermann, W., Forst, H., Haller, M., Bittl, M., Hoffmann, G. E., B�chler, M. W., Uhl, W. H., Peter, K., & Phospholipase A2 Study Group (1994) · Journal of Molecular Medicine · doi:10.1007/bf00180547 · Cited by 151
Kunz, D., Walker, G., Eberhardt, W., & Pfeilschifter, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.255 · Cited by 149
Kilbourn, R. G., Szabó, C., & Trabers, D. L. (1997) · Shock · doi:10.1097/00024382-199704000-00001 · Cited by 146
Altered Leukocyte Immunophenotypes in Septic Shock
Lin, R. Y.-W., Astiz, M. E., Saxon, J. C., & Rackow, E. C. (1993) · CHEST Journal · doi:10.1378/chest.104.3.847 · Cited by 138
Walker, G., Pfeilschifter, J., & Kunz, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16679 · Cited by 128
Corticosteroids and vascular tone: mapping the messenger maze
Walker, B. R., & Williams, B. C. (1992) · Clinical Science · doi:10.1042/cs0820597 · Cited by 112
Oppert, M., Reinicke, A., Gräf, K.-J., Barckow, D., Frei, U., & Eckardt, K.-U. (2000) · Intensive Care Medicine · doi:10.1007/s001340000685 · Cited by 106
Immunomodulation in Septic Shock
Briegel, J., JOCHUM, M., Gippner‐Steppert, C., & Thiel, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12suppl_1s70 · Cited by 103
Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis
Doughty, L., Carcillo, J. A., Kaplan, S. S., & Janosky, J. E. (1998) · Critical Care Medicine · doi:10.1097/00003246-199801000-00032 · Cited by 100
Almawi, W., Melemedjian, O., & Rieder, M. J. (1999) · Clinical Transplantation · doi:10.1034/j.1399-0012.1999.130501.x · Cited by 99
The Effect of Glucocorticoids on the Expression of L-Selectin on Polymorphonuclear Leukocyte
Nakagawa, M., Bondy, G. P., Waisman, D., Minshall, D., Hogg, J. C., & van Eeden, S. F. (1999) · Blood · doi:10.1182/blood.v93.8.2730 · Cited by 85
Grover, R., Lopez, A., Lorente, J. A., Steingrub, J. S., Bakker, J., Willatts, S. M., McLuckie, A., & Takala, J. A. (1999) · Critical Care Medicine · doi:10.1097/00003246-199901001-00021 · Cited by 83
Corticosteroids in septic shock
Matot, I., & Sprung, C. L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00002 · Cited by 76
Satoh, A., Miura, T., Satoh, K., Masamune, A., Yamagiwa, T., Sakai, Y., Shibuya, K., Takeda, K., Kaku, M., & Shimosegawa, T. (2002) · Pancreas · doi:10.1097/00006676-200210000-00006 · Cited by 73
Buckingham, J. C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15360.x · Cited by 72
McGill, S. N. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430230023005 · Cited by 62
Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure.
Endo, S., Inada, K., Kasai, T., Takakuwa, T., Yamada, Y., Koike, S., Wakabayashi, G., Niimi, M., Taniguchi, S., & Yoshida, M. (1995) · PubMed · Cited by 61
Meduri, G. U. (1999) · Sepsis · doi:10.1023/a:1009870524359 · Cited by 59
Serum MIP-1α and IL-8 in septic patients
Fujishima, S., Sasaki, J., Shinozawa, Y., Takuma, K., Kimura, H. J., Suzuki, M., Hori, S., Aikawa, N., & Kanazawa, M. (1996) · Intensive Care Medicine · doi:10.1007/bf01709331 · Cited by 59
An outcome predictive score for sepsis and death following injury
Hershman, M. J., Cheadle, W. G., Kuftinec, D., Polk, H. C., & George, C. D. (1988) · Injury · doi:10.1016/0020-1383(88)90042-3 · Cited by 58
Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids
Schneider, A. J. (1991) · Intensive Care Medicine · doi:10.1007/bf01720688 · Cited by 56
Groeneveld, P. H. P., Kwappenberg, K. M. C., Langermans, J. A. M., Nibbering, P. H., & Curtis, L. D. (1996) · Intensive Care Medicine · doi:10.1007/bf01709336 · Cited by 55
Contribution of cortisol deficiency to septic shock
Briegel, J., Forst, H., Hellinger, H., & Haller, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90575-a · Cited by 54
Arnalich, F., Hernánz, Á., Jiménez, M. L., López, J., Tato, E., Vázquez, J. J., & Montiel, C. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(96)00080-8 · Cited by 48
Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock.
Endo, S., Inada, K., Nakae, H., Arakawa, N., Takakuwa, T., YAMADA, Y., Shimamura, T., Suzuki, T., Taniguchi, S., & Yoshida, M. (1996) · PubMed · Cited by 47
EFFECTS OF A CORTICOSTEROID, BUDESONIDE, ON PRODUCTION OF BIOACTIVE IL-12 BY HUMAN MONOCYTES
Larsson, S., & Linden, M. (1998) · Cytokine · doi:10.1006/cyto.1998.0362 · Cited by 27
Research works printed but not linked: 13
- 1996, Br J Pharmacol, 118, 1
- 1999, Crit Care Med, 27, A33
- 2000, Endocr Rev, 21, 55
- 1993, JAMA, 270, 2957, 10.1001/jama.1993.03510240069035 · DOI · Paper page
- 1991, Lancet, 338, 507
- 1991, Intensive Care Med, 17, 436
- 1994, Clin Investig, 72, 782
- 1998, New Horiz, 6, 130
- 1996, Res Commun Mol Pathol Pharmacol, 91, 347
- 1999, Crit Care Med, 27, A33
- 1990, Proc Natl Acad Sci USA, 87, 10043, 10.1073/pnas.87.24.10043 · DOI · Paper page
- 1995, J Inflamm, 46, 212
- 1996, Proc Assoc Am Physicians, 108, 374
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationThe Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
“One crossover study showed hemodynamic and immunologic rebound effects after abrupt cessation of corticosteroids [188].”
BackgroundSelf-citationDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
“One crossover study showed hemodynamic and immunologic rebound effects after abrupt cessation of corticosteroids (110).”
BackgroundSelf-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“One crossover study showed hemodynamic and immunologic rebound effects after abrupt cessation of corticosteroids (312).”
BackgroundSelf-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
Metadata
- Authors
- Keh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Department of Anesthesiology and Intensive Care Medicine; Institute of Medical Immunology, Charité, Humboldt University; and Vivantes Klinikum Neukoelln, Berlin, Germany
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02
- Volume
- 167
- Issue
- 4
- Pages
- 512-520
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2148049376
- Cited by
- 600
- References
- 66
- Citations by year
- 2026: 6 · 2025: 26 · 2024: 8 · 2023: 12 · 2022: 15 · 2021: 23 · 2020: 20 · 2019: 22 · 2018: 15 · 2017: 22 · 2016: 17 · 2015: 15 · 2014: 26 · 2013: 20 · 2012: 21
- FWCI
- 28.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- septic shock, cortisol, low-dose hydrocortisone, adrenal insufficiency, nitric oxide, nitrite/nitrate, interleukin-6, interleukin-8, soluble E-selectin, neutrophil activation, soluble tumor necrosis factor receptor, IL-10, monocytes, HLA-DR expression, phagocytosis, IL-12, vasopressor requirement, hemodynamic stability, immunomodulation, corticosteroid withdrawal
- MeSH terms
- Adult, Anti-Inflammatory Agents, Dose-Response Relationship, Drug, Double-Blind Method, Female, Hemodynamics, Humans, Hydrocortisone, Immune System, Immunologic Factors, Infusions, Intravenous, Male, Middle Aged, Nitric Oxide, Shock, Septic, Down-Regulation, Cross-Over Studies, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.